Science Explorer Interactive view Map
Company · Beijing · China

Beijing Biocytogen (China)

In research, Beijing Biocytogen (China) stands highest in Life Sciences (#5,183 of 7,800 worldwide), Physical Sciences (#10,948 of 12,888 worldwide) and Medicine (#9,182 of 10,443 worldwide), 2022–2025. Relative to its size it is most specialised in Radiology, Nuclear Medicine and Imaging, Immunology and Oncology — Radiology, Nuclear Medicine and Imaging is 12.9× its share of world research.

bbctg.com.cnROR OpenAlex
World rank, 2022–2025
#11,399
of 28,054 · #19,035 all time
Rank in China
#2,021
of 3,058
Research works
507
▲ 104% vs 2013–17
Citations
5k
9.9 per fractional work
Top-10% rate
11.4%
record average 16.5%
Open access
41%
world 28%

What is Beijing Biocytogen (China) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Life SciencesDomain #5,183 of 7,800 15.4%80 #8963
Physical SciencesDomain #10,948 of 12,888 9.6%77 #18488
MedicineField #9,182 of 10,443 9.3%97 #15032
Health SciencesDomain #10,870 of 11,982 9.8%100 #17514

Each strip is that field’s whole ranked pool, with the notch where Beijing Biocytogen (China) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Life Sciences#8,963 #5,183
  2. Physical Sciences#18,488 #10,948
  3. Medicine#15,032 #9,182
  4. Health Sciences#17,514 #10,870
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Beijing Biocytogen (China) specialise in?

Where its research is concentrated relative to its size: Radiology, Nuclear Medicine and Imaging takes 12.9× the share of its output that it takes of world research.

  1. Radiology, Nuclear Medicine and ImagingSubfield · 30.5 works13×
  2. ImmunologySubfield · 22.3 works12×
  3. OncologySubfield · 27.8 works9.4×
  4. Immunology and MicrobiologyField · 23.5 works8.9×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.71× its world share, 9 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.76× its world share, 39 worksBiochemistry, Geneti…Immunology and Microbiology: 8.89× its world share, 24 worksImmunology and Micro…Neuroscience: 1.30× its world share, 6 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.06× its world share, 3 worksPharmacology, Toxico…Chemical Engineering: 0.73× its world share, 1 worksChemical EngineeringChemistry: 0.64× its world share, 3 worksChemistryComputer Science: 1.03× its world share, 21 worksComputer ScienceEarth and Planetary Sciences: 0.13× its world share, 0 worksEarth and Planetary …Energy: 0.87× its world share, 2 worksEnergyEngineering: 0.91× its world share, 36 worksEngineeringEnvironmental Science: 0.29× its world share, 4 worksEnvironmental ScienceMaterials Science: 0.98× its world share, 9 worksMaterials ScienceMathematics: 0.20× its world share, 1 worksMathematicsPhysics and Astronomy: 0.21× its world share, 1 worksPhysics and AstronomyDentistry: 0.38× its world share, 0 worksDentistryHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 1.92× its world share, 97 worksMedicineNursing: 1.10× its world share, 1 worksNursingVeterinary: 2.10× its world share, 1 worksVeterinaryBusiness, Management and Accounting: 0.40× its world share, 3 worksBusiness, Management…Decision Sciences: 0.41× its world share, 1 worksDecision SciencesPsychology: 0.12× its world share, 1 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.9×. Every wedge is a field page.

Who are the top researchers at Beijing Biocytogen (China)?

Ranked on the composite score, Hengliang Wang, Li Zhu and Xiankai Liu lead among researchers whose main affiliation is Beijing Biocytogen (China).

  1. 1 Hengliang Wang China · #729,101 worldwide 46 citations · 31 works
  2. 2 Li Zhu China · #936,890 worldwide 76 citations · 34 works
  3. 3 Xiankai Liu China · #1,108,497 worldwide 28 citations · 19 works
  4. 4 Jing Wei China · #1,130,864 worldwide 51 citations · 39 works
  5. 5 Chao Pan China · #1,322,300 worldwide 32 citations · 24 works
  6. 6 Erling Feng China · #1,539,609 worldwide 24 citations · 16 works
  7. 7 Bin Zhuang China · #1,542,901 worldwide 4 citations · 19 works
All ranked researchers at Beijing Biocytogen (China)

Which keywords describe research at Beijing Biocytogen (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer Immunotherapy, Immunotherapy and Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation24▲ 81×3 topics
  2. Monoclonal Antibodies20▲ 87×3 topics
  3. Therapeutic Antibodies20▲ 109×2 topics
  4. Antibody Engineering20▲ 137×1 topic
  5. Fc Receptors20▲ 137×1 topic
  6. Inflammation16▲ 2.9×47 topics
  7. Cancer Immunotherapy15▲ 37×3 topics
  8. Deep Learning14▲ 1.57×51 topics
  9. Immunotherapy14▲ 7.5×11 topics
  10. Cancer13▲ 3.6×28 topics
  11. Chemotherapy11▲ 6.2×12 topics
  12. Immunity11▲ 11×9 topics
  13. Machine Learning11▲ 1.31×36 topics
  14. Targeted Therapy11▲ 18×5 topics
  15. Tumor Regression10▲ 35×2 topics
  16. Innate Immunity10▲ 12×6 topics
  17. Monoclonal Antibody10▲ 69×2 topics
  18. Breast Cancer9▲ 14×4 topics
  19. PET Imaging9▲ 20×4 topics
  20. Cancer Treatment9▲ 14×7 topics
  21. Tumor Microenvironment8▲ 7.3×7 topics
  22. Antigen Presentation8▲ 36×2 topics
  23. Metastatic8▲ 50×2 topics
  24. HER28▲ 109×1 topic
  25. Trastuzumab8▲ 69×1 topic
  26. Dendritic Cells8▲ 34×2 topics
  27. Lymphoma8▲ 19×3 topics
  28. Radioimmunotherapy8▲ 106×1 topic
  29. Radiopharmaceuticals8▲ 106×1 topic
  30. Tumor Antigen8▲ 47×1 topic
  31. Vaccine Adjuvants8▲ 47×1 topic
  32. CAR T Cells7▲ 37×1 topic
  33. Chimeric Antigen Receptor7▲ 37×1 topic
  34. Gene Therapy7▲ 14×5 topics
  35. Immune Response6▲ 3.9×14 topics
  36. NK Cell Recognition4▲ 26×1 topic
  37. Natural Killer Cells4▲ 26×1 topic
  38. Immune Checkpoint Blockade4▲ 15×1 topic
  39. PD-1 and PD-L14▲ 15×1 topic
  40. Tumor Targeting4▲ 8.8×3 topics

Which research topics does Beijing Biocytogen (China) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Radiopharmaceutical Chemistry and Applications and Immunotherapy and Immune Responses.

Monoclonal and Polyclona…20Monoclonal and Polyclonal Antibodies Research: 20 fractional worksHER2/EGFR in Cancer Rese…8HER2/EGFR in Cancer Research: 8 fractional worksRadiopharmaceutical Chem…8Radiopharmaceutical Chemistry and Applications: 8 fractional worksImmunotherapy and Immune Responses: 8 fractional worksCAR-T cell therapy research: 7 fractional worksImmune Cell Function and…4Immune Cell Function and Interaction: 4 fractional worksCancer Immunotherapy and Biomarkers: 4 fractional worksFinTech, Crowdfunding, Digital Finance: 3 fractional worksCancer Research and Treatments: 3 fractional worksGlycosylation and Glycoproteins Research: 2 fractional works
Radiology, Nuclear Medicine and ImagingOncologyImmunologyManagement Information Systems2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 20 works
  2. 2 HER2/EGFR in Cancer Research Oncology 8 works
  3. 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 8 works
  4. 4 Immunotherapy and Immune Responses Immunology 8 works
  5. 5 CAR-T cell therapy research Oncology 7 works
  6. 6 Immune Cell Function and Interaction Immunology 4 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 4 works
  8. 8 FinTech, Crowdfunding, Digital Finance Management Information Systems 3 works
  9. 9 Cancer Research and Treatments Biotechnology 3 works
  10. 10 Glycosylation and Glycoproteins Research Molecular Biology 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.0%not open59.0%

World: 28% of research is openly available.

with international co-authors14.3%domestic only85.7%

World: 19% is written across borders.

How has Beijing Biocytogen (China)'s research output changed?

Output in 2018–2022 was 104% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Beijing

All research institutions in Beijing

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.